Acadia Healthcare Intrinsic Stock Value – Analysts Predict $91.22 Target Price for Acadia Healthcare as Shares Receive “Moderate Buy” Rating from Experts

☀️Trending News

With a strong commitment to quality care and evidence-based treatment, ACADIA HEALTHCARE ($NASDAQ:ACHC) has established itself as a trusted name in the healthcare industry. Recently, market analysts have taken notice of ACADIA HEALTHCARE’s potential for growth and success. Eight analysts have collectively given the company a “Moderate Buy” rating, indicating a positive outlook for its performance in the market. This rating is based on the company’s financial performance, growth potential, and overall market trends. One of the key factors contributing to ACADIA HEALTHCARE’s positive rating is its strong financial performance. This growth can be attributed to the expansion of its facilities and services, as well as increased demand for mental health treatment due to the ongoing pandemic.

Additionally, ACADIA HEALTHCARE’s strategic acquisitions have also played a significant role in its success. These acquisitions have not only expanded ACADIA HEALTHCARE’s geographic reach but also diversified its service offerings, making it more attractive to potential clients and investors. Another key driver for ACADIA HEALTHCARE’s positive rating is its potential for continued growth. The company has a strong pipeline of new facilities set to open in the coming years, further expanding its reach and revenue potential. Furthermore, with increasing awareness and acceptance of mental health treatment, the demand for ACADIA HEALTHCARE’s services is expected to continue to rise, providing a promising outlook for the company’s future growth. With a solid financial foundation, strategic acquisitions, and a promising outlook for the future, ACADIA HEALTHCARE is well-positioned to continue its success in the behavioral healthcare industry.

Price History

On Thursday, analysts made bold predictions for Acadia Healthcare, a leading provider of behavioral healthcare services. The stock opened at $78.6 and closed at $79.2, representing a 1.1% increase from its previous closing price of $78.3. This increase in stock price comes after experts gave the company a “Moderate Buy” rating, indicating that they believe the stock has the potential for growth. One of the main reasons for this positive outlook is the average target price of $91.22 set by analysts. The “Moderate Buy” rating given by experts is also encouraging for investors. This rating suggests that while there may be some level of risk associated with investing in Acadia Healthcare, the potential for growth outweighs these risks.

Additionally, this rating indicates that analysts see potential for the company to outperform its peers in the industry. It’s worth noting that this positive sentiment towards Acadia Healthcare is not unwarranted. With a strong financial performance and a solid market presence, the company seems to be on track to reach its target price in the near future. Investors would be wise to keep an eye on Acadia Healthcare as it continues to grow and potentially exceed expectations in the behavioral healthcare industry. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Acadia Healthcare. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Acadia Healthcare. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Acadia Healthcare. More…

Key Ratios Snapshot

Some of the financial key ratios for Acadia Healthcare are shown below. More…

Analysis – Acadia Healthcare Intrinsic Stock Value

After conducting a thorough analysis of ACADIA HEALTHCARE, I would highly recommend examining its fundamentals before making any investment decisions. As financial analysts at GoodWhale, we understand the importance of evaluating a company’s core strengths and weaknesses before determining its potential for growth. One key aspect to consider is the intrinsic value of ACADIA HEALTHCARE’s stock. Our proprietary Valuation Line places the company’s intrinsic value at around $79.8. This calculation takes into account the company’s financials, market trends, and growth potential. Therefore, with the current stock price of $79.2, we can conclude that ACADIA HEALTHCARE is trading at a fair price. However, it is still essential to conduct further research on the company’s fundamentals to fully understand its current financial standing and potential for future growth. This includes analyzing its revenue and earnings growth, profit margins, and debt levels. Additionally, keeping an eye on market trends and industry developments can provide valuable insights into the company’s performance. It is also worth noting that ACADIA HEALTHCARE operates in the healthcare industry, which is known for its stability and consistent demand. With an increasing global focus on mental health and addiction treatment, the company is well-positioned to capitalize on this growing market. In conclusion, while our analysis shows that ACADIA HEALTHCARE is currently trading at a fair price, it is crucial to thoroughly examine its fundamentals before making any investment decisions. Keeping track of market trends and industry developments can also provide valuable insights into the company’s future performance. More…

Peers

The Company offers inpatient and outpatient behavioral healthcare services to children, adolescents, adults, and seniors through its facilities in the United States, United Kingdom, and Puerto Rico. Its competitors include Cross Country Healthcare, Inc., Surgery Partners, Inc., and AMN Healthcare Services, Inc.

– Cross Country Healthcare Inc ($NASDAQ:CCRN)

Cross Country Healthcare, Inc. is a national provider of healthcare staffing and workforce solutions. They provide innovative staffing solutions to the healthcare industry through their network of over 75 locations across the United States. Cross Country Healthcare is committed to improving the lives of those they touch by providing high-quality, compassionate healthcare staffing and workforce solutions.

– Surgery Partners Inc ($NASDAQ:SGRY)

Surgery Partners Inc is a healthcare services company that owns and operates surgical facilities and ancillary services in the United States. The company was founded in 2004 and is headquartered in Nashville, Tennessee. As of 2022, Surgery Partners had a market capitalization of $2.36 billion and a return on equity of 26.22%. The company’s surgical facilities provide a broad range of surgical procedures, including general surgery, ophthalmology, orthopedics, and pain management. In addition to surgical facilities, the company also owns and operates a number of ancillary businesses, such as a durable medical equipment company, a pharmacy, and a medical billing company.

– AMN Healthcare Services Inc ($NYSE:AMN)

The company’s market cap and ROE are impressive, and it is clear that the company is doing well. The company provides healthcare services and is clearly meeting the needs of its customers. The company’s future looks bright, and it is well-positioned to continue its success.

Summary

Analysts have set a target price of $91.22 for shares of ACADIA Healthcare Company, Inc. This indicates a potential upside for investors, as the stock is currently trading at a lower price. Eight ratings have been given for the company, with a consensus recommendation of “Moderate Buy.” This suggests that analysts believe the company has potential for growth and profitability, but may also face some challenges. Investors considering investing in ACADIA Healthcare should carefully consider these ratings and conduct their own analysis to determine if it aligns with their investment goals and risk tolerance.